The additional financing values Tempus at $2bn. The round includes Baillie Gifford, funds and accounts managed by T. Rowe Price, Revolution Growth, New Enterprise Associates (NEA) and other existing
The post Tempus secures additional $110m in financing appeared first on Compelo Medical Devices.
Original Article: Tempus secures additional $110m in financing